Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

Fig. 2

Adjusted mean change from baseline in a pre-dose morning FEV1, and b 2-h post-dose FEV1 (overall population, ITT). ‡p < 0.001. Data are adjusted mean and 95% CI. The N values are the number of patients included in the statistical model. FEV1 forced expiratory volume in 1 s, ITT intention-to-treat, BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrronium, BUD budesonide, CI confidence interval

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us